yingweiwo
  1. Home
  2. Products
  3. Signaling Pathways
  4. GPCR & G Protein
  5. CXCR

CXCR

CXCR

CXCR related products

Structure Cat No. Product Name CAS No. Product Description
3-[[3-[(二甲基氨基)羰基]-2-羟基苯基]氨基]-4-[[(R)-1-(5-甲基呋喃-2-基)丙基]氨基]-3-环丁烯-1,2-二酮 V3792 Navarixin 473727-83-2 Navarixin (formerly known as MK-7123; SCH527123; PS291822) is a novel potent and specific allosteric antagonist of CXCR1 and CXCR2 with antitumor and anti-inflammatory activity and is able to sensitize cells to oxaliplatin in preclinical colon cancer models.
AT009 V129565 AT009 AT009 is a humanized monoclonal antibody against CXCR4 that can be used in cancer research.
ATI-2341 V2585 ATI-2341 1337878-62-2 ATI-2341 (ATI2341), a pepducin targeting the C-X-C chemokine receptor type 4 (CXCR4), is a novel and selective allosteric agonist of CXCR4 with anti-inflammatory and anticancer activity.
AZD8797 V3799 AZD8797 911715-90-7 AZD8797 (AZD-8797) is a novel, selective, orally bioavailable and allosteric non-competitive modulator of the human CX3CR1 receptor with potential anti-Inflammatory and immunomodulatory activity.
CXCL9(74-103) V106153 CXCL9(74-103) CXCL9(74-103) is a derivative peptide of CXCL9, which has a high affinity for glycosaminoglycan (GAG) and can bind to GAG.
CXCR2 antagonist 2 V51660 CXCR2 antagonist 2 2647464-91-1 CXCR2 antagonist 2 is a potent CXCR2 antagonist for cancer immune research with IC50 of 95 nM.
CXCR2-IN-1 V3791 CXCR2-IN-1 1873376-49-8 CXCR2-IN-1 is a novel CNS (central nervous system) penetrant antagonist of CXCR2 with a pIC50 of 9.3.
CXCR3 antagonist 1 V83390 CXCR3 antagonist 1 870998-13-3
CXCR4-IN-2 V79685 CXCR4-IN-2 CXCR4-IN-2 (compound A1) is a bifunctional fluorinated small molecule, a potent CXCR4 inhibitor (antagonist) with anti-cancer activity.
Danirixin V3796 Danirixin 954126-98-8 Danirixin (formerly known asGSK-1325756; GSK1325756) is a novel, potent small molecule CXCR2 antagonist being developed as a potential anti-inflammatory drug for COPD.
Eltrekibart V135035 Eltrekibart 2484883-56-7 Eltrekibart is a monoclonal antibody against CXCL human IgG4κ.
HFB-100204 V137346 HFB-100204 HFB-100204 is a human monoclonal antibody (mAb) that targets CXCR5.
Hypoglaucin A V112540 Hypoglaucin A 93528-39-3 Hypoglaucin A is a CXCR3 antagonist with an IC50 value of 0.47 μM.
LIT-927 V4031 LIT-927 2172879-52-4 LIT-927 (LIT927 ) is a novel potent, locally and orally bioactive neutraligand for the chemokine CXCL12 with anti-inflammatory and anticancer activity.
PS372424 hydrochloride V74886 PS372424 hydrochloride 1596362-29-6 PS372424 HCl, a three-amino acid (AA) fragment of CXCL10, is a specific human CXCR3 agonist/activator with anti-inflammatory activity.
SB225002 V1490 SB225002 182498-32-4 SB225002 (SB 225002; SB-225002) is a novel, potent, and selective non-peptide antagonist of chemokine receptor CXCR2 with potential anti-inflammatory activity.
SCH 563705 V3795 SCH 563705 473728-58-4 SCH-563705 (SCH563705) is a novel potent and orally bioactive antagonist of CXCR2 and CXCR1 with anti-Inflammatory and immunomodulatory activity.
SCH-900875 V144672 SCH-900875 907206-98-8 SCH-900875 is an orally effective, blood-brain barrier-penetrating, and highly selective CXCR3 receptor inhibitor, which also exhibits high selectivity for CXCR1 and CXCR2 receptors.
SDF-1α (human) (TFA) V86585 SDF-1α (human) (TFA) SDF-1α (human) TFA is a monocyte chemoattractant that binds to the CXCR4 receptor.
SLW131 V145032 SLW131 681511-84-2 SLW131 is a CCR7 antagonist with good affinity and a Ki value of 9.85 nM.
Contact Us
Tel: 1-708-310-1919 Fax: 1-708-557-7486 Email: [email protected] Frequently Asked Questions
Subscribe to our E-newsletter
Name
E-mail

Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved

linkedin facebook
Contact Us
Home Product Cart Member